RAINBOW CHILDRENS MEDICARE
|
|
BOM : 543524     NSE : RAINBOW     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Apr 01,2025 |
Price(EOD): ₹ 1,368.95
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 13,908.53 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
RAINBOW CHILDRENS MEDICARE | 2% | 5.6% | 12.2% |
MAX HEALTHCARE INSTITUTE | -7.6% | 6.6% | 36.5% |
APOLLO HOSPITALS ENTERPRISE | -0.2% | 7.1% | 6.3% |
FORTIS HEALTHCARE | 6.3% | 11.8% | 69.2% |
GLOBAL HEALTH | -1.4% | 3.2% | -10.6% |
NARAYANA HRUDAYALAYA | 1.8% | 12.4% | 33.1% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | -3.3% | 16.2% | 55.3% |
DR LAL PATHLABS | -4% | 1.9% | 9.2% |
ASTER DM HEALTHCARE | 8.2% | 18.9% | 19.8% |
FUNDAMENTAL ANALYSIS OF RAINBOW CHILDRENS MEDICARE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF RAINBOW CHILDRENS MEDICARE
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
58.23
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 238.74 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] 11.13
P/B Calculated based on Book Value of Rs 1,249.27 Cr
[Latest Year - Mar2024 - Consolidated Results ] 9.35
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,486.86 Cr
[Latest Qtr - Dec2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
8570% 10326% -3% |
SHARE PRICE MOMENTUM OF RAINBOW CHILDRENS MEDICARE
RAINBOW CHILDRENS MEDICARE vs SENSEX
DEBT OF RAINBOW CHILDRENS MEDICARE
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0 0 0.06 0.02 |
0 0 0.07 0.02 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF RAINBOW CHILDRENS MEDICARE
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2024 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF RAINBOW CHILDRENS MEDICARE
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-4.64% -8.65% -10.46% -12.74% |
18.49% 13.79% 11.28% 10.18% |
QtrlyTrend |
0 | |
Latest Qtr: Dec2024 | ||
Quarterly Result Analysis → |
RAINBOW CHILDRENS MEDICARE related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 1.5% | 3.4% | 7.5% |
BSE MIDSMALLCAP | -1.1% | 3.4% | 8.1% |
BSE 500 | -2.2% | 3.2% | 4.8% |
BSE SMALLCAP | -2.5% | 3.6% | 9.2% |
BSE 250 SMALLCAP INDEX | -2.5% | 3.7% | 4.9% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY 500 | -2.2% | 3.2% | 5.3% |
NIFTY TOTAL MARKET | -2.2% | 3.2% | 5.5% |
NIFTY500 MULTICAP 50:25:25 | -2.3% | 3.3% | 6% |
NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | -2.3% | 3.4% | NA |
NIFTY SMALLCAP 250 | -2.4% | 4.1% | 6.1% |
You may also like the below Video Courses
FAQ about RAINBOW CHILDRENS MEDICARE
Is RAINBOW CHILDRENS MEDICARE good for long term investment?
As on Apr 01,2025, the Fundamentals of RAINBOW CHILDRENS MEDICARE look Strong and hence it may be good for long term investment! See Financial Performance of RAINBOW CHILDRENS MEDICARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is RAINBOW CHILDRENS MEDICARE UnderValued or OverValued?
As on Apr 01,2025, RAINBOW CHILDRENS MEDICARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of RAINBOW CHILDRENS MEDICARE ?
As on Apr 01,2025, the Intrinsic Value of RAINBOW CHILDRENS MEDICARE is Rs. 15.79 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 15.79
Fair Value [Median EV / Sales Model] : Rs. 13.13
Fair Value [Median Price / Sales Model] : Rs. 1,408.72
Estimated Median Fair Value of RAINBOW CHILDRENS MEDICARE : Rs. 15.79
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.